Evidence map›Paper›PMID 31231423›Full record

ArticleFrontiers in genetics2019

Beyond the Big Five: Investigating Myostatin Structure, Polymorphism and Expression in

Maria Favia, Robert Fitak, Lorenzo Guerra, Ciro Leonardo Pierri, Bernard Faye, Ahmad Oulmouden, Pamela Anna Burger, Elena Ciani

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Refining theAnimals : an open access journal from MDPI · 2022
    Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Maria FaviaDepartment of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari "Aldo Moro", Bari, Italy.
Robert FitakResearch Institute of Wildlife Ecology, Vetmeduni, Vienna, Austria.
Lorenzo GuerraDepartment of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari "Aldo Moro", Bari, Italy.
Ciro Leonardo PierriDepartment of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari "Aldo Moro", Bari, Italy.
Bernard FayeCIRAD, UMR SELMET, Montpellier, France.
Ahmad OulmoudenDépartement Sciences du Vivant, Université de Limoges, Limoges, France.
Pamela Anna BurgerResearch Institute of Wildlife Ecology, Vetmeduni, Vienna, Austria.
Elena CianiDepartment of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari "Aldo Moro", Bari, Italy.
CTI BioPharma (Italy) · ITUniversity of Bari Aldo Moro · ITDuke University · USSystèmes d’élevage méditerranéens et tropicaux · FRUniversité de Limoges · FR

Funding

Austrian Science Fund FWF P 29623
6 · The paper itself

Abstract

Myostatin, a negative regulator of skeletal muscle mass in animals, has been shown to play a role in determining muscular hypertrophy in several livestock species, and a high degree of polymorphism has been previously reported for this gene in humans and cattle. In this study, we provide a characterization of the myostatin gene in the dromedary (

Indexed as

3D protein comparative modelingCamelus dromedariusDigital Droplet PCRmyostatinNext Generation SequencingSingle Nucleotide Polymorphismsskeletal muscleWestern Blot

Identifiers

PMID31231423
PMCPMC6566074
OpenAlexW2944700777

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.